Evaluation of the SpeeDx<i>ResistancePlus®</i>GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in<i>Neisseria gonorrhoeae</i>
The journal of antimicrobial chemotherapy/Journal of antimicrobial chemotherapy